The Development Program Sample Clauses
The Development Program. The parties shall undertake a development and manufacturing scale-up program for the Product, as described in the attached Exhibits B and C, with the overall objective of creating commercial-scale manufacturing capability and obtaining all regulatory approvals necessary for the commercialization of the Product (hereinafter, the “Development Program”). Subject to the terms and conditions of this Agreement, including but not limited to Section 2.8 below, the parties will cooperate with each other using commercially reasonable good faith efforts to accomplish the goals of the Development Program; however, if the Product or associated processes are not successfully developed, neither party shall be liable to the other party solely by reason of that fact.
The Development Program. (a) RELIANT hereby engages EURAND, and EURAND hereby agrees, to perform the work described in Exhibit A (the “Development Program”). In connection therewith, EURAND shall make its best efforts to carry out the Development Program in accordance with the timetables and budgets therein and shall make available such of its scientific, engineering, manufacturing and other personnel, necessary to perform its obligations in accordance with the terms hereof. Any material change in the Development Program shall be agreed to in writing between Eurand and RELIANT.
(b) EURAND shall receive prior written authorization to commence each phase of the Development Program. RELIANT may cancel the Development Program at the conclusion of each phase prior to commencement of the subsequent phase.
The Development Program. 14 5.1 Conduct of the Development Program ....................... 14 5.1.1. General .......................................... 14 5.1.2. Development Plan ................................. 15 5.1.3. Initial and Updated Development Plan ............. 15 5.1.4. Execution and Performance ........................ 16 5.1.5. Attendance at Regulatory Meetings ................ 16 5.2.
The Development Program. 11 4.1. Conduct of the Development Program............................................................ 11 4.1.1. General................................................................................ 11 4.1.2. Annual Development Plan............................................................... 11 4.1.3.
The Development Program. The Development Program shall have a term (the "Development Term") which commences upon the date an R&D Candidate is selected for Development and shall continue until the JSC agrees to cease the Development of the last remaining R&D Candidate or until all Regulatory Approvals for all R&D Candidates have been received in the Territory.
The Development Program. 4 2.1 GENERAL....................................................... 4 2.2
The Development Program. Promptly following receipt of the amount set forth in Section 2 below, Institution shall use diligent efforts to develop Invader(R) polymorphism and mRNA transcript assays described in the Protocol, subject to Company providing Institution the materials described in Exhibit B (collectively, the "Company Materials"). Upon completion of the Development Program with respect to each such particular assay, Institution agrees to provide Company with the number of assay determinations set forth in the Protocol for such particular assay, including enzyme, buffer and Invader probes for such analyte (collectively, the "Institution Materials"). Accordingly, Institution shall, after consultation with Company, direct and perform the Development Program in a professional and diligent manner, all in accordance with the Protocol and the terms of this Agreement.
The Development Program. 5.1. Conduct of the Development Program.
The Development Program. (a) ECR hereby engages EURAND, and EURAND hereby agrees, to perform the work described in Exhibit A (the “Development Program”). In connection therewith, EURAND shall make available such of its PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST. scientific, engineering, manufacturing and other personnel, which, in its discretion, are necessary to perform its obligations in accordance with the terms hereof.
(b) EURAND shall receive prior written authorization to commence each phase of the Development Program. ECR may cancel the Development Program at the conclusion of each phase prior to commencement of the subsequent phase without liability to EURAND or ECR. In the event that ECR fails to authorize the next succeeding phase within 90 days after EURAND concludes a phase, this shall constitute cancellation by ECR.
The Development Program. 16
4.1 Conduct of the Development Program".........................